A chapter contribution to the Encyclopedia of AIDS by two Simon Fraser University graduate students is helping researchers to expand their knowledge on HIV/AIDS. Anh Le and Aniqa Shahid, who are both completing their Master of Science degrees in the Faculty of Health Sciences, recently made a contribution to an encyclopedic publication that indexes current research on HIV. The Encyclopedia of AIDS…
Read More
Microbes exist everywhere – in water, air, soil, plants and animals, and from the coldest regions of the Antarctic to the boiling hydrothermal vents at the bottom of the sea. According to microbiologist Brett Finlay, there are far more bacteria on Earth than there are stars in the sky, and despite their microscopic size, the Earth’s microbes weigh more than…
Read More
Heartbreaking loss has led to a leap in progress for beluga whale conservation science: the beluga genome has been sequenced for the first time.   BC Cancer’s Michael Smith Genome Sciences Centre (GSC) worked with genetic material from the mother and daughter beluga whales who were cared for at Vancouver Aquarium for almost three decades. The Genome BC funded research…
Read More
Right now, 25% of children who survive blood and marrow transplants go on to develop chronic graft-versus-host disease (cGvHD), an incurable condition that can cause lifelong pain and disability. “Blood and marrow transplants can cure cancer and immune disease in patients who have few other treatment options, but they also can cause cGvHD,” says Dr. Kirk Schultz. “We want to preserve…
Read More
When we talk about female representation in science, we’re rarely talking about test subjects. We tend to want more women behind the microscope, not under it. Neuroscience is one of the most skewed fields when it comes to testing on female physiology. One review found single-sex brain studies using male animals outnumbered those using females 6.7 to one. Aarthi Gobinath, a…
Read More
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to “reboot” the body’s innate immune system, has just published collaborative research with Dartmouth College detailing the mechanism of action and efficacy of Qu’s lung-targeted SSI, QBKPN, for the treatment of lung cancer. It has long been recognized that acute infection can potentially trigger the…
Read More
As part of its Industry Innovation Program (I² Fund), Genome BC is investing CAD $750,000 in a local microbiome testing company—Vancouver-based Microbiome Insights (MBI), which provides next-generation-sequencing-based analytical testing and consulting services to microbiome researchers in academia and industry. The new funding adds to the company’s recent round of equity financing, which closed in October. Microbiomes are the communities of…
Read More
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to “reboot” the body’s innate immune system, has just published collaborative research with Dartmouth College detailing the mechanism of action and efficacy of Qu’s lung-targeted SSI, QBKPN, for the treatment of lung cancer. It has long been recognized that acute infection can potentially trigger the…
Read More

Revving Your Nanoscale Engine

Biological molecular machines are microscopic proteins that carry out biological tasks by converting between different forms of energy. Many molecular machines burn chemical fuel to produce movement, similar to a car engine, only 100 million times smaller. An example of this is the protein kinesin, which transports cargo along cellular filaments to specific destinations within cells, and supports critical functions such…
Read More